Literature DB >> 10704022

Spectrophotometric and spectrofluorimetric determination of etodolac and aceclofenac.

N M El Kousy1.   

Abstract

Two simple, sensitive and reproducible spectrophotometric and spectrofluorimetric methods were adopted for the analysis of the anti-inflammatory drugs, etodolac and aceclofenac. The first method is based on the formation of coloured complexes between the drugs and p-dimethylaminobenzaldehyde reagent (PDAB) in the presence of sulfuric acid and ferric chloride. Measurement of the absorbances was carried out at 591.5 and 545.5 nm for etodolac and aceclofenac, respectively. Regression analysis of Beer's plots showed good correlation in the concentration ranges 10-80 and 8-55 microg ml(-1), respectively. The second was the spectrofluorimetric method in which samples of etodolac in ethanol showed native fluorescence at a lambda = 345 nm when excitation was at 235 nm and samples of aceclofenac in the phosphate buffer pH 8 showed native fluorescence at lambda = 355 nm when excitation was at 250 nm. The calibration graph was rectilinear from 96 to 640 ng ml(-1) for etodolac and from 2 to 8 microg ml(-1) for aceclofenac. The proposed methods are applied successfully for the determination of the two drugs in bulk powder with a mean accuracy of 100.48+/-0.85 and 100.03+/-0.38 in the PDAB method and of 100.61+/-0.79 and 99.88+/-0.45 in the spectrofluorimetric method. Applicability of the proposed methods was examined by analysing dosage forms of the investigated drugs. Recoveries were 98.77-101.46 and 98.65-102.10% for the two methods, respectively and RSD values were 0.6-0.7 and 0.35-1.06% respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10704022     DOI: 10.1016/s0731-7085(99)00019-9

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Spectrofluorimetric determination of etodolac, moxepril HCl and fexofenadine HCl using europium sensitized fluorescence in bulk and pharmaceutical preparations.

Authors:  Soad S Abd el-Hay; Christa L Colyer; Wafaa S Hassan; Abdalla Shalaby
Journal:  J Fluoresc       Date:  2011-08-19       Impact factor: 2.217

2.  Development and validation of simultaneous spectrophotometric methods for drotaverine hydrochloride and aceclofenac from tablet dosage form.

Authors:  S A Shah; D R Shah; R S Chauhan; J R Jain
Journal:  Indian J Pharm Sci       Date:  2011-05       Impact factor: 0.975

3.  Reversed phase-high performance liquid chromatographic method for simultaneous estimation of tolperisone hydrochloride and etodolac in a combined fixed dose oral formulations.

Authors:  Mit J Patel; R Badmanaban; C N Patel
Journal:  Pharm Methods       Date:  2011-04

4.  Simple spectrophotometric methods for estimation of aceclofenac from bulk and formulations.

Authors:  A Bose; Pp Dash; Mk Sahoo
Journal:  Pharm Methods       Date:  2010-10

5.  Spectrophotometric determination of etodolac in pure form and pharmaceutical formulations.

Authors:  Ayman A Gouda; Wafaa S Hassan
Journal:  Chem Cent J       Date:  2008-04-14       Impact factor: 4.215

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.